title: Improvement of serological discrimination between herpesvirus-infected animals and animals vaccinated with marker vaccines.
abstract: Control/eradication plans of bovine herpesvirus 1 (BHV1) and suid herpesvirus 1 (SHV1) infections involve vaccination with inactivated or attenuated gE-deleted marker vaccines and associated companion serological tests to discriminate naturally infected from vaccinated animals. Blocking or competitive enzyme-linked immunosorbent assays (ELISAs) have been designed for the detection of specific antibodies against BHV1 or SHV1 gE glycoprotein. The antigen source usually consists of a crude viral preparation in which gE is associated with other envelope glycoproteins. Such assays suffer from a lack of specificity which is not due to serological cross-reactions with other pathogens. Interestingly, false-positive results occur with sera collected from multivaccinated cattle or pigs. After multivaccination with a marker vaccine, the binding of the conjugated monoclonal antibody used as a tracer, could be hampered by antibodies directed against the other viral glycoproteins. In order to validate the steric hindrance hypothesis, a simple preadsorption of such samples was carried out with a preparation of antigen devoid of gE, prior to the blocking ELISA itself. The decrease in antibody concentrations against the major glycoproteins, clearly leads to a better discrimination between positive and negative samples; that is between infected and multivaccinated animals, without significant loss of sensitivity. This experiment confirms the steric hindrance hypothesis, therefore serum preadsorption could be an easy way to improve the specificity of currently available diagnostic tests.
authors.affiliation: Synbiotics Europe, 2 Rue Alexander Fleming, 69367 Cedex 07, Lyon, France. david.lehmann@aventis.com
authors.forename: D
authors.initials: D
authors.lastname: Lehmann
authors.forename: R
authors.initials: R
authors.lastname: Sodoyer
authors.forename: S
authors.initials: S
authors.lastname: Leterme
authors.forename: D
authors.initials: D
authors.lastname: Crevat
mesh_terms: D000818:Animals; D000956:Antigens, Viral / Q000276:immunology; D002417:Cattle; D002418:Cattle Diseases / Q000097:blood / Q000276:immunology / Q000821:virology*; D004797:Enzyme-Linked Immunosorbent Assay / Q000379:methods / Q000662:veterinary*; D006566:Herpesviridae Infections / Q000097:blood / Q000276:immunology* / Q000821:virology; D007242:Herpesvirus 1, Bovine / Q000276:immunology* / Q000302:isolation & purification; D011558:Herpesvirus 1, Suid / Q000276:immunology* / Q000302:isolation & purification; D013552:Swine; D013553:Swine Diseases / Q000097:blood / Q000276:immunology / Q000821:virology*; D014764:Viral Proteins / Q000276:immunology; D014765:Viral Vaccines / Q000276:immunology*
chemical_list: D000956:Antigens, Viral; D014764:Viral Proteins; D014765:Viral Vaccines